Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
92.24
-3.35 (-3.50%)
Jun 2, 2026, 4:00 PM EDT - Market closed
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
JAKAFI Product Revenue | 3.14B | 3.09B | 2.79B | ||||||||||||
JAKAFI Product Revenue Growth | 1.56% | 10.76% | 7.65% | ||||||||||||
OPZELURA Product Revenue | 702.77M | 678.46M | 508.29M | ||||||||||||
OPZELURA Product Revenue Growth | 3.58% | 33.48% | 50.44% | ||||||||||||
ICLUSIG Product Revenue | 139.99M | 134.07M | 114.32M | ||||||||||||
ICLUSIG Product Revenue Growth | 4.42% | 17.28% | 2.42% | ||||||||||||
PEMAZYRE Product Revenue | 90.83M | 86.73M | 81.75M | ||||||||||||
PEMAZYRE Product Revenue Growth | 4.73% | 6.09% | -2.26% | ||||||||||||
MINJUVI/MONJUVI Product Revenue | 164.25M | 144.58M | 119.24M | ||||||||||||
MINJUVI/MONJUVI Product Revenue Growth | 13.61% | 21.25% | 221.76% | ||||||||||||
NIKTIMVO Product Revenue | 193.11M | 151.64M | - | ||||||||||||
NIKTIMVO Product Revenue Growth | 27.35% | - | - | ||||||||||||
ZYNYZ Product Revenue | 104.74M | 66.35M | 3.19M | ||||||||||||
ZYNYZ Product Revenue Growth | 57.85% | 1983.23% | 154.80% | ||||||||||||
Total Product Revenue | 4.54B | 4.35B | 3.62B | ||||||||||||
Total Product Revenue Growth | 4.18% | 20.32% | 14.34% | ||||||||||||
JAKAVI Royalty Revenue | 471.14M | 457.73M | 418.84M | ||||||||||||
JAKAVI Royalty Revenue Growth | 2.93% | 9.29% | 13.94% | ||||||||||||
OLUMIANT Royalty Revenue | 150.21M | 144.60M | 135.57M | ||||||||||||
OLUMIANT Royalty Revenue Growth | 3.88% | 6.66% | -0.42% | ||||||||||||
TABRECTA Royalty Revenue | 26.27M | 26.70M | 22.75M | ||||||||||||
TABRECTA Royalty Revenue Growth | -1.61% | 17.39% | 27.84% | ||||||||||||
Other Royalty Revenue | 9.86M | 7.88M | 2.17M | ||||||||||||
Other Royalty Revenue Growth | 25.15% | 262.87% | 10.37% | ||||||||||||
Total Royalty Revenue | 657.48M | 636.91M | 579.33M | ||||||||||||
Total Royalty Revenue Growth | 3.23% | 9.94% | 10.67% | ||||||||||||
Milestone and Contract Revenue | 167.00M | 150.00M | 43.00M | ||||||||||||
Milestone and Contract Revenue Growth | 11.33% | 248.84% | 514.29% | ||||||||||||
Revenue (Other) | -193.11M | -151.64M | 1,000.00 | ||||||||||||
Revenue (Total) | 5.36B | 5.14B | 4.24B | ||||||||||||
Revenue (Total) Growth | 4.28% | 21.22% | 14.76% |
Updated Apr 28, 2026. Data Source: Fiscal.ai.